Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Fore Biotherapeutics Announces First Patient Dosed in Global Phase 2 Trial Evaluating FORE8394 in BRAF-Mutated Solid and Brain Tumors
Fore Biotherapeutics, a precision oncology company dedicated to developing innovative treatments that provide a better […]
Forge Biologics Reports Positive FBX-101 Clinical Updates for Patients with Krabbe Disease at WORLDSymposium
Forge Biologics, a genetic medicines development and manufacturing organization, announced today that Maria Escolar, M.D., […]
MEI Pharma and Infinity Pharmaceuticals Announce Definitive Merger Agreement to Advance Three Promising Clinical Oncology Candidates
MEI Pharma, a clinical-stage pharmaceutical company focused on advancing new therapies for cancer, and Infinity […]
Shuttle Pharmaceuticals Expands Laboratory Space to Advance Drug Development Pipeline and Diagnostic Capabilities
Shuttle Pharmaceuticals, a discovery and development stage specialty pharmaceutical company focused on improving the outcomes […]
Genprex Announces Groundbreaking Data from Non-Human Primate Study Evaluating Novel Gene Therapy to Treat Type 1 Diabetes
Genprex, a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer […]
Sangamo Therapeutics Announces Evidence of Clinical Benefit in Phase 1/2 STAAR Study in Fabry Disease
Sangamo Therapeutics, a genomic medicine company, today announced updated preliminary data as of the October […]
ViiV Healthcare announces positive data demonstrating long-acting injectable Cabenuva is as effective as daily oral Biktarvy for the treatment of HIV-1
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi […]
Radionetics Oncology Appoints Istvan Molnar, M.D. as Chief Medical Officer
Radionetics Oncology, a pharmaceutical company focused on the discovery and development of novel radiotherapeutics for […]
CLEARA Biotech Appoints Nicholas J. Sarlis, MD, PhD as Chief Medical Officer and Head of Clinical Development
CLEARA Biotech, a preclinical-stage biotechnology company focused on developing innovative, proprietary therapies for treating different […]
Modus Therapeutics Announces Positive Topline Data from its Phase 1b LPS Provocation Study Evaluating the Potential of Sevuparin for Treatment of Sepsis
Modus Therapeutics, a company developing innovative treatments for patients with major unmet medical needs, announces […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more